Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects.
Groner, B
Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects. [electronic resource] - International journal of cancer Mar 1997 - 682-7 p. digital
Publication Type: Journal Article
0020-7136
10.1002/(sici)1097-0215(19970317)70:6<682::aid-ijc10>3.0.co;2-c doi
Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Carcinoma--drug therapy
Carrier Proteins--pharmacology
Exotoxins--pharmacology
Female
Glycoproteins--pharmacology
Liver--drug effects
Mice
Mice, Nude
Neoplasm Transplantation
Neoplasms, Experimental--drug therapy
Neuregulin-1
Rats
Recombinant Fusion Proteins--pharmacology
Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects. [electronic resource] - International journal of cancer Mar 1997 - 682-7 p. digital
Publication Type: Journal Article
0020-7136
10.1002/(sici)1097-0215(19970317)70:6<682::aid-ijc10>3.0.co;2-c doi
Animals
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Carcinoma--drug therapy
Carrier Proteins--pharmacology
Exotoxins--pharmacology
Female
Glycoproteins--pharmacology
Liver--drug effects
Mice
Mice, Nude
Neoplasm Transplantation
Neoplasms, Experimental--drug therapy
Neuregulin-1
Rats
Recombinant Fusion Proteins--pharmacology